Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 6;8(2):137–146. doi: 10.4292/wjgpt.v8.i2.137

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

PMC Copyright notice

Rates of virological response. Patients with undetectable viral loads during and post treatment. A: At treatment week 4 and post-treatment week 12 (sustained virological response) by genotype; B: At treatment week 4 and post-treatment week 12 (sustained virological response) by fibrosis stage; C: At treatment week 4 and post-treatment week 12 (sustained virological response) by CT-met and CT-unmet. Data for 5 patients were lost: genotype 1, data from three patients were lost; genotype 3 and 4, a patient data in each genotype were lost. Data for 4 patients were lost. Data for 1 patient were lost. GT: Genotype; RVR: Undetectable HCV RNA at week 4; SVR: Sustained virological response; CT: Clinical trial.